Acesso livre
Acesso livre

Arquivos do dia: Novembro 26, 2021

EMA recomenda a aprovação da vacina da Pfizer-BioNTech para crianças de 5 a 11 anos.

26 Nov, 2021 | 12:06h

Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 – European Medicines Agency

Conteúdos relacionados:

RCT: Pfizer vaccine shows 90.7% efficacy for preventing Covid-19 in children 5 to 11 years of age.

What COVID vaccines for young kids could mean for the pandemic.

CDC advisers endorse Pfizer’s Covid-19 vaccine for kids 5-11.

FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children ages 5 to 11.

 

Comentário no Twitter

 

Revisão | Prevenção e tratamento de trombose em pacientes internados com pneumonia por COVID-19.

26 Nov, 2021 | 12:04h

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia – The Lancet Respiratory Medicine

Variante fortemente mutada do coronavírus põe os cientistas em alerta – “Pesquisadores estão correndo para determinar se uma variante de alta transmissibilidade na África do Sul é uma ameaça à efetividade das vacinas contra COVID.”

26 Nov, 2021 | 12:03h

Heavily mutated coronavirus variant puts scientists on alert – Nature

Ver também:

Covid: New heavily mutated variant B.1.1.529 in South Africa raises concern – BBC

WHO calls special meeting to discuss new Covid variant found in South Africa with ‘a large number of mutations’ – CNBC

New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – Health Policy Watch

Scientists warn of new Covid variant with high number of mutations – The Guardian

South Africa detects new COVID variant with many mutations – MedicalXpress

 

Comentário relacionado no Twitter (fio – clique para saber mais)

 

Editorial | Vacine-se o mundo.

26 Nov, 2021 | 12:01h

Vax the world – Science

 

Comentário do autor no Twitter

 

M-A | Comparação da eficácia clínica das vacinas contra COVID-19.

26 Nov, 2021 | 11:59h

Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis – Scientific Reports

M-A | Sintomas persistentes após infecção por SARS-CoV-2 entre crianças e jovens – “Melhor qualidade de estudo foi associada com menor prevalência de todos os sintomas, exceto perda de olfato e sintomas cognitivos.”

26 Nov, 2021 | 11:58h

Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies – Journal of Infection

Conteúdos relacionados:

Review: Long COVID symptoms in children rarely persist beyond three months.

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

[Preprint] Respostas sorológicas ao reforço de vacina contra COVID-19 na Inglaterra.

26 Nov, 2021 | 11:56h

Serological responses to COVID-19 booster vaccine in England – medRxiv

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Força-tarefa internacional DORIS realiza recomendações sobre definição de remissão do lúpus eritematoso sistêmico.

26 Nov, 2021 | 11:54h

2021 DORIS definition of remission in SLE: final recommendations from an international task force – Lupus Science & Medicine

Diretriz sobre angiossarcomas cutâneos – Atualização 2021.

26 Nov, 2021 | 11:53h

S1-Guideline Cutaneous Angiosarcomas – Update 2021 – Journal of the German Society of Dermatology

Revisão sistemática | Quantificação do impacto anticolinérgico e sedativo em idosos com polifarmácia.

26 Nov, 2021 | 11:52h

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.